LC106

DRUG2 trials

Sponsors

Massachusetts General Hospital, Caroline Mitchell

Conditions

Bacterial Vaginosis

Early Phase 1

Vaginal lIve Biotherapeutic RANdomized Trial

CompletedNCT06135974

Massachusetts General HospitalBacterial Vaginosis

Start: 2024-02-01End: 2025-02-18Updated: 2025-03-25

Impact of Clinician-administered Vaginal Live Biotherapeutic Product

Not yet recruitingNCT07305844

Caroline MitchellBacterial Vaginosis

Start: 2026-02-10End: 2026-05-30Target: 71Updated: 2026-01-20

Related Papers

Bacterial Vaginosis [BV] knowledge, attitudes and behavioural changes after BV diagnosis among women enrolled in a clinical trial in Boston, USA and Vulindlela, South Africa: a qualitative study.

2025-12-12

Randomized trial of multi-strain <i>Lactobacillus crispatus</i> vaginal live biotherapeutic products after antibiotic therapy for bacterial vaginosis: study protocol for VIBRANT (vaginal lIve biotherapeutic RANdomized trial).

2025-09-161 citations